Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity

Dexcom inks glucose biosensor partnership with Life Time

Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business

Micron Biomedical raises $33M for needle-free drug delivery tech

Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation

Aerosol drug delivery company Aerogen to expand in Ireland

BD increases U.S. syringe, IV catheter manufacturing

Henry Schein completes acquisition of CGM supplier Acentus

Insulet rolls out Omnipod 5 in more European countries

Spirit Health to make new CGM available in UK

Dexcom expects sales to grow 14% in 2025

Senseonics to consider reverse stock split, reports strong Eversense 365 interest

Hedia, Glooko launch personalized bolus insulin dosing tech

Phillips Medisize enhances inhaled drug delivery portfolio with Vectura acquisition

Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech

CeQur raises $120M to support insulin delivery tech

Beta Bionics is proposing an IPO

PreEvnt to unveil non-invasive blood glucose alert device

Abbott, Dexcom settle global CGM patent litigation

The 5 most-read Drug Delivery Business News stories of 2024

BD hit with FDA warning related to Pyxis medication management

Oura raises $200M from investors including Dexcom

Vivani Medical initiates first-in-human GLP-1-eluting implant study

Lilly gets nod to market locally manufactured insulin in Egypt

Dexcom launches generative AI platform for glucose biosensing